Glenmark Life Science Share Price

₹ 1,481.30

+₹33.70 (2.33%)
1D
Last updated 03 Nov, 2026, 15:50 IST
NSE: ALIVUS
|
Pharmaceuticals

Glenmark Life Science Share Price Today

As of 3 Nov 2026, Glenmark Life Science share price is ₹1,481.30. The stock opened at ₹1,447.60, compared to its previous close of ₹1,447.60. During today's trading session, Glenmark Life Science share price moved in the range of ₹1,440.00 to ₹1,501.50, with an average price of ₹1,470.75 for the day. Looking at its last 52-week, the stock has touched a low of ₹819.00 and a high of ₹1,505.00. On the performance front, Glenmark Life Science share price has increased by 39.44% over the last six months and is up 60.05% on a year-on-year basis.

Share price over the last 1 day rose from 1457.90 to 1480.00, ranging between 1448.20 and 1495.80.
₹1,440.00
2.33% up today
₹1,501.50
1D LOW
1D HIGH

Glenmark Life Science Stock Insights

Stock Performance
OutperformingBeat Nifty by 1.46 % in last 1 month
Shareholding Pattern
PromoterPromoter decreased stake by 0.03%
Shareholding Pattern
DIIDII increased stake by 13.97%
Shareholding Pattern
FIIFII increased stake by 7.07%
Glenmark Life Science stock performance
Open₹1,447.60
High₹1,501.50
Low₹1,440.00
Prev. close₹1,447.60
Glenmark Life Science trading activity
Volume5,25,467
Average traded price₹1,484.82
Last traded time03:50:02 03 Nov
Last traded quantity35
Circuit
L
H
₹1,158.10
₹1,737.10
52-week
L
H
₹819.00
₹1,505.00
Mkt Cap Cr
17,814.14
P/E
26.6
P/B
4.91
ROA
15.43%
ROE
18.44%
ROCE
24.26%
Quick Ratio
3.85
EV/EBITDA
17.83

Based on fundamentals, this stock's

Performance: 5 out of 5, Excellent
Performance
Excellent
Alivus Life outperforming all market indices
Valuation: 1 out of 5, Overvalued
Valuation
Overvalued
Alivus Life appears overvalued compared to its peers
Earnings: 3 out of 5, Neutral
Earnings
Neutral
Alivus Life earnings growth is positive
Peer Comparison
Peer comparison — key ratios
NameMkt Cap CrP/EP/BROAROEROCEQuick RatioEV/EBITDA
Sun Pharmaceutical Industries4,24,202.4238.614.759.61%13.79%18.65%2.3122.27
Divis Laboratories2,57,902.7390.3115.7614.6%15.32%19.56%3.558.97
Torrent Pharmaceuticals1,74,402.4783.099.494.7%11.42%11.37%0.7533.6
Laurus Labs1,26,811.2895.1720.9211.58%22.11%20.91%0.6854.77
Zydus Lifesciences1,24,089.4826.934.568.57%18.59%17.35%0.9116.42
Dr. Reddy's Laboratories1,11,868.0340.542.884.79%7.21%8.58%1.3519.05
Cipla1,11,647.7239.123.156.6%8.18%10.8%2.521.03
Mankind Pharma1,02,195.6245.155.817.82%12.76%14.68%0.7425.01
Aurobindo Pharma96,536.9026.132.566.34%9.25%11.76%1.1512.38
Lupin91,870.1616.454.0714.47%23.76%24.88%1.429.83

Auto-generated based on historical fundamentals; not a recommendation to buy/sell.

Glenmark Life Science Company Background

ISIN
INE03Q201024
Sector Market Cap
₹ 17,814.14 Cr

Alivus Life Sciences Limited, formerly Glenmark Life Sciences Limited, is an India-based developer and manufacturer of non-commoditized, active pharmaceutical ingredients (APIs) in chronic therapeutic areas. The Company is providing contract development and manufacturing (CDMO) services to a range of multinational and specialty pharmaceutical companies. Its primary therapy areas include cardiovascular (CVS) disease, central nervous system (CNS) disorders, diabetes, oncology, pain management (anti-migraine, analgesic) and anti-infectives (antibiotic). It also develops APIs in the therapeutic areas such as antifungal, anti-histaminic, anti-acne, anti-emetic, ophthalmologic agent, urinary and anti-spasmodic. It has a diversified portfolio of around 151 molecules & supplies its products to customers in India, Europe, North America, Latin America, Japan and the rest of the world. Its four manufacturing facilities are located in Ankleshwar, Dahej, Mohol and Kurkumbh.

Glenmark Life Science Financial Highlights

  • Revenue: Glenmark Life Science reported revenue of ₹1,885.98 crore in FY21 vs ₹1,549.30 crore in FY20. It showed an increase of 21.73% on a yearly basis.
  • Operating Profit: Glenmark Life Science reported an operating profit of ₹470.94 crore in FY21 vs ₹421.07 crore in FY20. It showed an increase of 11.84% on a year-on-year basis.
  • Net Profit: Glenmark Life Science reported a net profit of ₹351.58 crore in FY21 vs ₹313.10 crore in FY20. It showed an increase of 12.29% on a yearly basis.

Glenmark Life Science Quarterly Result Highlights

  • Glenmark Life Science reported revenue of ₹701.91 crore in Sep 2026, compared with ₹662.81 crore in Jun 2026, representing an increase of 5.90% on a quarter-on-quarter (QoQ) basis.
  • Glenmark Life Science reported an operating profit of ₹261.97 crore in Sep 2026, compared with ₹212.22 crore in Jun 2026, representing an increase of 23.44% on a quarter-on-quarter (QoQ) basis.
  • Glenmark Life Science reported a profit of ₹196.75 crore in Sep 2026, compared with ₹160.08 crore in Jun 2026, reflecting an increase of 22.91% on a QoQ basis.
  • The earnings per share (EPS) of Glenmark Life Science stood at ₹45.99 during Sep 2026.

Data Source: BSE, Company announcements

Securities shown are illustrative, not recommendations. Past performance does not guarantee future results.

Promoters
74.85%
FII
5.93%
Other DII
1.74%
Retail and other
12.19%
Mutual funds
5.29%
Foreign Institutional Investor (FII)
FII shareholding by period
Dec 20255.09%
Mar 20265.29%
Jun 20265.54%
Sep 20265.93%

Glenmark Life Science Investment Returns

1 day
+2.28%
1 week
+14.71%
1 month
+5.34%
1 year
+60.05%
3 years
+134.20%
5 years
+131.36%

Glenmark Life Science Share Price History

Glenmark Life Science share price history by day, showing open and close prices and the percentage change
Day
Open / Close
Change %
02 Nov 26
₹1,421.00 / ₹1,447.60
+2.28%
30 Oct 26
₹1,451.00 / ₹1,415.30
+1.28%
29 Oct 26
₹1,400.00 / ₹1,397.40
-0.14%
28 Oct 26
₹1,343.60 / ₹1,399.40
+4.15%
Show more

Glenmark Life Science Financials

Full statement

Income Statement · Consolidated

Income Statement · Consolidated — all values in INR Crore
ParticularsMar 2019Mar 2020Mar 2021
Revenue886.861,549.31,885.98
Operating profit228.3421.07470.94
Net profit195.59313.1351.58

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Revenue₹2,551.83₹2,386.88₹2,283.21₹2,161.22
Other Income₹60.41₹34.57₹12.04₹28.96
Total Revenue₹2,612.24₹2,421.45₹2,295.26₹2,190.18
Total Expenses₹1,835.28₹1,767.32₹1,663.97₹1,561.57
Profit Before Tax₹751.31₹654.13₹631.29₹628.61
Tax₹186.83₹168.50₹160.40₹161.65
Profit After Tax₹564.48₹485.63₹470.89₹466.96
EPS - Basic₹45.99₹39.63₹38.43₹38.11
EPS - Diluted₹45.90₹39.52₹38.38₹38.11

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax₹751.31₹654.13₹631.29₹628.61
Income before WC changes₹867.21₹734.85₹710.56₹673.23
Change in Assets-₹115.86-₹199.12-₹99.96-₹304.44
Change in Liabilities-₹12.68₹18.75-₹34.12₹90.78
Change in WC-₹128.54-₹180.38-₹134.08-₹213.66
Cash flow from Operations₹565.41₹391.52₹413.52₹306.01
Cash flow from Investing-₹570.15-₹615.65-₹116.48-₹146.75
Cash flow from Financing-₹64.34-₹6.23-₹279.44-₹387.59
Total Cash Flow-₹69.08-₹230.35₹17.59-₹228.33
Cash (Start of the year)₹71.06₹301.41₹283.82₹512.16
Cash (End of the year)₹1.98₹71.06₹301.41₹283.82

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Non-Current Assets₹1,333.54₹1,076.30₹934.41₹851.81
Current Assets₹2,649.36₹2,335.16₹1,916.00₹1,850.34
Total Assets₹3,982.90₹3,411.45₹2,850.41₹2,702.15
Current Liabilities₹508.04₹470.16₹438.77₹496.54
Net Current Asset₹2,141.33₹1,865.00₹1,477.23₹1,353.80
Non-Current Liabilities₹142.73₹123.92₹79.32₹67.40
Equity Capital₹3,332.13₹2,817.37₹2,332.32₹2,138.21
Total Equity & Liabilities₹3,982.90₹3,411.45₹2,850.41₹2,702.15
* All values are in INR Crore
Glenmark Life Science market depth
Bid quantityBid priceAsk priceAsk quantity
001481.3384
0000
0000
0000
0000
Total bid quantity0
Total ask quantity384
Glenmark Life Science technical summary
Bearish indicators4
Neutral indicators3
Bullish indicators1
OverallSlightly Bearish
by SEBI experts

Expert Pick

EXPPICK
Stop-loss
Stop-loss is locked. Sign in to view.
Entry price
Entry price is locked. Sign in to view.
Target
Target is locked. Sign in to view.
Indicator
Value
Verdict
RSI (14)
66.57
Neutral
ATR (14)
64.09
Neutral
STOCH(9,6)
80.67
Bearish
STOCH RSI (14)
100
Bearish
ADX(9)
41.15
Bearish
UO(9)
53.77
Neutral
ROC(12)
7.39
Bullish
WillR(14)
-19.33
Bearish
Period
Simple value
Exponential vaue
5D
1400.66
1397.98
10D
1331.14
1366.11
20D
1339.58
1352.09
50D
1363.46
1335.24
100D
1270.35
1274.75
Volume trend — traded volume by day
3 Nov5L
2 Nov6L
30 Oct11L
29 Oct2L
28 Oct1L
27 Oct1L
Average4L

Technical indicators used here are for indicative purposes only. Kindly do not treat it as an investment or trading advice

Compare against other stocks

Glenmark Life Science
Pharmaceuticals
Add Stock
Add Another

Glenmark Life Science Returns Calculator

Ex-date: 01 Sep 2026

Top Gainers

KRBL Share Price
₹401.45
+38.45 (+10.59%)
MARICO Share Price
₹878.40
+79.85 (+10%)
BALRAMCHIN Share Price
₹654.80
+54.9 (+9.15%)
TRIDENT Share Price
₹23.79
+1.58 (+7.11%)
AEGISLOG Share Price
₹1177.10
+77 (+7%)
See more

Top Losers

KEC Share Price
₹316.35
-32.65 (-9.36%)
GNFC Share Price
₹465.05
-45.95 (-8.99%)
PRAJIND Share Price
₹254.63
-16.5 (-6.09%)
AIAENG Share Price
₹3389.70
-217.6 (-6.03%)
GESHIP Share Price
₹1536.50
-63.9 (-3.99%)
See more

Glenmark Life Science Share Price FAQs

Please be aware that Glenmark Life Science stock prices are subject to continuous fluctuations due to various factors.